Total Funding
5
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3537738
Alchemia Limited is a listed Australian biopharmaceutical company with an FDA approved drug and a late stage oncology product.
Acquired by 
Panther Biotechnology
- Charles Walker: CEO
- Nicolas Rey: Founder
About the Company
Alchemia Limited is a listed Australian biopharmaceutical company (ASX:ACL) with an FDA approved drug (Fondaparinux sodium) and a late stage oncology product pipeline derived from the HyACT platform. In addition, Alchemia has a drug discovery platform, VAST®, derived from Alchemia’s chemistry expertise.
